| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/22/2004 | CN1167420C Azabanzimidazole-based compounds for modulating serine/threonine protein kinase function |
| 09/22/2004 | CN1167417C Use of curcumin and its derivatives in preparing medicine for chronic granulocytic leukemia |
| 09/21/2004 | US6795776 Crystallographic structure of the androgen receptor ligand binding domain |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794541 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 09/21/2004 | US6794523 Anticancer agents, antitumor agents; leukemia |
| 09/21/2004 | US6794516 Synthesis of clasto-lactacystin β-lactone and analogs thereof |
| 09/21/2004 | US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease |
| 09/21/2004 | US6794507 Compounds that inhibit factor Xa activity |
| 09/21/2004 | US6794494 Can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells; for diagnosis and therapy of primary tumors |
| 09/21/2004 | US6794416 Treatment of chronic obstructive pulmonary disease including chronic bronchitis, emphysema and asthma in humans that smoke or smoked cigarettes using aerosol or nebulizing device with or without concommitant treatment |
| 09/21/2004 | US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 09/21/2004 | US6794403 Substituted benzoxazoles as estrogenic agents |
| 09/21/2004 | US6794398 Preventive/remedies for liver diseases |
| 09/21/2004 | US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/21/2004 | US6794395 Substituted indolinones, their manufacture and their use as medicaments |
| 09/21/2004 | US6794384 Hydroxylation activated drug release |
| 09/21/2004 | US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/21/2004 | US6794370 Method for treating cancer using camptothecin derivatives and 5-fluorouracil |
| 09/21/2004 | US6794364 Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides |
| 09/21/2004 | US6794363 Isolated amyloid inhibitor protein (APIP) and compositions thereof |
| 09/21/2004 | US6794178 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 09/21/2004 | US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans |
| 09/21/2004 | US6794151 c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence |
| 09/21/2004 | US6794137 Detecting exposure of a cell to ultraviolet radiation; obtain cells, screen for preferential gene expression, monitor cells for adjusted tubulin protein expression |
| 09/21/2004 | US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells |
| 09/21/2004 | CA2458085A1 Transcriptional activity assay |
| 09/21/2004 | CA2155843C Novel urea derivatives, their preparation and use |
| 09/16/2004 | WO2004078987A1 A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
| 09/16/2004 | WO2004078970A1 Branched neutral amino acid transporters acting as single molecule |
| 09/16/2004 | WO2004078781A1 Protein-binding doxorubicin peptide derivatives |
| 09/16/2004 | WO2004078770A1 Bifunctional heterocyclic compounds and methods of making and using the same |
| 09/16/2004 | WO2004078764A1 Gm-95-containing antitumor effect potentiator, combined antitumor preparation and antitumor agent |
| 09/16/2004 | WO2004078758A1 Novel fused heterocycles and uses thereof |
| 09/16/2004 | WO2004078748A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078747A1 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078746A2 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatrory disorders |
| 09/16/2004 | WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent |
| 09/16/2004 | WO2004078695A1 Method for the purification of crocetin |
| 09/16/2004 | WO2004078677A2 Enhanced delivery of sphingolipids |
| 09/16/2004 | WO2004078206A1 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/16/2004 | WO2004078205A1 Targeting a protein prc1 for the treatment of pancreatic cancer |
| 09/16/2004 | WO2004078202A1 Clostridial neurotoxins for treating uterine disorders |
| 09/16/2004 | WO2004078191A1 Composition for treating hepatitis c |
| 09/16/2004 | WO2004078184A1 Use of adenosine receptor agonists in therapy |
| 09/16/2004 | WO2004078140A2 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF |
| 09/16/2004 | WO2004078137A2 Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 09/16/2004 | WO2004078133A2 Antineoplastic combinations comprising a rapamycin derivative and an aromatase inhibitor |
| 09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
| 09/16/2004 | WO2004078123A2 Early prostate cancer antigens (epca), polynucleotide sequences encoding them, and their use |
| 09/16/2004 | WO2004078110A2 Fused imizadoles as transforming growth factor (tgf) inhibitors |
| 09/16/2004 | WO2004078097A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 09/16/2004 | WO2004063711A3 Use of adiponectin to diagnose and treat malignancy |
| 09/16/2004 | WO2004062592A3 2-o sulfatase compositions and related methods |
| 09/16/2004 | WO2004055513A3 Use of cd137 antagonists for the treatment of tumors |
| 09/16/2004 | WO2004050096A3 Phosphoantigens for regulating an immune response |
| 09/16/2004 | WO2004048409A3 Mutants of the tumor necrosis factor alpha with deletion of n-terminal amino acids |
| 09/16/2004 | WO2004046188A3 Anti-activated ras antibodies |
| 09/16/2004 | WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 09/16/2004 | WO2004043389B1 Methods of treating cancer and related methods |
| 09/16/2004 | WO2004013180A3 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 09/16/2004 | WO2004005540A3 Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |
| 09/16/2004 | WO2004004632A3 Flavone derivatives as inhibitors of cyclin-dependent kinases |
| 09/16/2004 | WO2003088898A3 Compositions and methods for the diagnosis and treatment of tumor |
| 09/16/2004 | WO2003083041A8 Cripto-specific antibodies |
| 09/16/2004 | WO2003073989A3 Nucleoside 5'-monophosphate mimics and their prodrugs |
| 09/16/2004 | WO2003065971A3 Non-myeloablative tolerogenic treatment with tyrphostins |
| 09/16/2004 | WO2003053457A8 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 09/16/2004 | WO2003052048A3 Nucleic acid-associated proteins |
| 09/16/2004 | WO2003045318A3 Manipulation of cytokine levels using cd83 gene products |
| 09/16/2004 | WO2003043583A3 Treatment of immunological disorders using anti-cd30 antibodies |
| 09/16/2004 | WO2002099043A8 P5CRS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/16/2004 | US20040181076 Reaction of carbazolone, forrmaldehyde and amine compound in nonaqueous solution and bonding to water, solvent |
| 09/16/2004 | US20040181066 Tyrosine kinase inhibitors |
| 09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
| 09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 09/16/2004 | US20040181047 33 human secreted proteins |
| 09/16/2004 | US20040181041 Fusion protein capable of inducing programmed cell death for use in treatment cell proliferative diseases and infection |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181036 Mutant forms of cholera holotoxin as an adjuvant |
| 09/16/2004 | US20040181035 Modified colony stimulating factor for treatment of hematopoietic disorder |
| 09/16/2004 | US20040180962 Dosage forms having prolonged active ingredient release |
| 09/16/2004 | US20040180956 calcium salt is calcium trifluoroacetate; to prepare medicaments with cytotoxic and antitumoral activity |
| 09/16/2004 | US20040180955 to establish a low circulating concentration of suramin in the patient of below about 200 mu, then administering cytotoxic agent |
| 09/16/2004 | US20040180949 conjugates of pharmaceutical agents and a highly lipphilic group, a C22 unbranched carbon chain; render the activity of these compounds selective for colon tissue, breast tissue and central nervous system tissue |
| 09/16/2004 | US20040180944 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction |
| 09/16/2004 | US20040180938 More preferred compound is (1Z,3E)-1-methyl-1-(4-carboxyphenyl)-2-methoxycarbonyl-3-(2-methylpyridin-4-yl)aminocarbonyl-4-(3-methoxyphenyl)butadiene; for the treatment of acute coronary symptoms |
| 09/16/2004 | US20040180929 Nitrogen compounds such as 4-Benzyloxy-4-(4-chlorophenyl)-3-(3,4-difluorobenzyloxy)-piperidine, administered as oncoprotein or ubiquitin-conjugating enzyme antagonists for prophylaxis of cancer; anticarcinogenic agents |
| 09/16/2004 | US20040180917 Novel tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing the same |
| 09/16/2004 | US20040180914 5-Cyano-2-aminopyrimidine derivatives |
| 09/16/2004 | US20040180911 for the treatment of a proliferative disease, such as a tumor |
| 09/16/2004 | US20040180901 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 09/16/2004 | US20040180899 tyrosine kinase inhibitors |
| 09/16/2004 | US20040180891 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 09/16/2004 | US20040180890 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 09/16/2004 | US20040180889 Cancer treatment; such as [4-(2,5-dimethyl-pyrrol-1-yl)-3-methyl-phenoxy]-acetic acid |
| 09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/16/2004 | US20040180881 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/16/2004 | US20040180858 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |